The global prevalence of latent tuberculosis: a systematic review and meta-analysis

Cohen, Adam, Mathiasen, Victor Dahl, Schön, Thomas, Wejse, Christian·2019·European Respiratory Journal
DOI 10.1183/13993003.00655-2019

Cited by (547)

Items 201–300 of 547

  1. Prevalence and predictors of tuberculosis infection among people living with HIV in a high tuberculosis burden context
    Lilian N. Njagi, Videlis Nduba, Marianne Mureithi, Jared Ongechi Mecha · 2023 · BMJ Open Respiratory Research
  2. A Comparative Study on the Mechanism of Delayed-Type Hypersensitivity Mediated by the Recombinant Mycobacterium tuberculosis Fusion Protein ESAT6-CFP10 and Purified Protein Derivative
    Xiaonan Guo, Weixin Du, Junli Li, Jiaxin Dong, Xiaobing Shen, Cheng Su, Aihua Zhao, Yongge Wu, Miao Xu · 2023 · International Journal of Molecular Sciences
  3. The oral microbiome of newly diagnosed tuberculosis patients; a pilot study
    Muhammad Asif Shahzad, Muhammad Saeed, Humaira Amin, Nada O. Binmadi, Zafar Ullah, Sana Bibi, Simon C. Andrew · 2024 · Genomics
  4. Screening for Latent Tuberculosis Infection in People Living with HIV: TUBHIVIT Project, a Multicenter Italian Study
    Luca Pipitò, Elena Delfina Ricci, Paolo Maggi, Giuseppe Vittorio De Socio, Giovanni Francesco Pellicanò, Marcello Trizzino, Raffaella Rubino, Alessandra Lanzi, Lorenzo Crupi, I Capriglione et al. · 2024 · Viruses
  5. Survival of Cancer Patients with Co-Morbid Tuberculosis in Thailand
    Pallop Siewchaisakul, Sirinya Nanthanangkul, Chalongpon Santong, Krittika Suwanrungruang, Patravoot Vatanasapt · 2021 · Asian Pacific Journal of Cancer Prevention
  6. Descriptive Epidemiology of the Tuberculosis Service Delivery Project Beneficiaries in Northwest Syria: 2019-2020
    Hani Alashavi, Mahmoud Daher, Dato Chorgoliani, Molham Saflo, Mohammed Zeidan, Fedi Huseyinibrahim, Eyup Ismail, Abdul Raouf Haj Yousef, Khalil Ayat, Ekrem Elobayd et al. · 2021 · Frontiers in Public Health
  7. Systematic review of latent tuberculosis infection research to inform programmatic management in Ireland
    James O’Connell, Eoghan de Barra, Samuel J. McConkey · 2021 · Irish Journal of Medical Science (1971 -)
  8. Diagnostic Performance of a Novel CXCL10 mRNA Release Assay for Mycobacterium tuberculosis Infection
    Liping Pan, Mailing Huang, Hongyan Jia, Guofang Deng, Yu Chen, Rongrong Wei, Mingxia Zhang, Xin Li, Qi Sun, Mutong Fang et al. · 2022 · Frontiers in Microbiology
  9. Diagnostic performance of microRNA-29a in active pulmonary tuberculosis: a systematic review and meta-analysis
    Xiaoying Li, Yuehong Xu, Pu Liao · 2023 · Clinics
  10. Latent M. tuberculosis infection is associated with increased inflammatory cytokine and decreased suppressor of cytokine signalling (SOCS)‐3 in the diabetic host
    Kiran Iqbal Masood, Muhammad Irfan, Qamar Masood, Maliha Yameen, Bushra Jamil, Nanik Ram, Shoaib Rao, Martı́n E. Rottenberg, Zahra Hasan · 2021 · Scandinavian Journal of Immunology
  11. Serious Infection Rates Among Patients with Select Autoimmune Conditions: A Claims-Based Retrospective Cohort Study from Taiwan and the USA
    Wen‐Nan Huang, Ching‐Yi Chuo, Ching‐Heng Lin, Yi‐Ming Chen, Wei‐Szu Lin, Katie Tuckwell, Nicholas S. Jones, Joshua Galanter, Lisa Lindsay · 2022 · Rheumatology and Therapy
  12. Genetic Susceptibility to Tuberculosis and the Utility of Polygenic Scores in Population Stratification
    Mariia A. Dashian, German Alexandrovich Shipulin, Andrei A. Deviatkin · 2025 · International Journal of Molecular Sciences
  13. Prevalence and management of tuberculosis infection in Apulian rheumatologic patients treated with biologics: An observational cohort 10‐year study from the BIOPURE registry
    M. Fornaro, S. Stano, D. Goletti, A. Semeraro, F. Cantatore, Nicola Maruotti, S. Colella, A. Abbruzzese, Leonardo Santo, Emanuela Praino et al. · 2022 · European Journal of Clinical Investigation
  14. A regression predictive model for QuantiFERON-TB Gold Plus ® indeterminate results in immunosuppressed patients
    Rahma Bellagha, Tarak Dhaouadi, Aouatef Riahi, Wahiba Ben Rehouma, Hajer Jedidi, Leïla Mouelhi, Leila ABDELMOULA, Taieb Ben Abdallah, Yousr Lakhoua Gorgi, Imen Sfar · 2024 · SAGE Open Medicine
  15. Antigen-Induced IL-1RA Production Discriminates Active and Latent Tuberculosis Infection
    César Sánchez, Luis Jaramillo‐Valverde, Silvia Capristano, Gilmer Solis, Alonso Soto, Julio Valdivia‐Silva, Julio A. Poterico, Heinner Guio · 2023 · Microorganisms
  16. Prevalence and incidence of tuberculosis infection among healthcare workers in chest diseases hospitals, Bangladesh: Putting infection control into context
    Md Saiful Islam, Emily S. Gurley, Sayera Banu, Kamal Hossain, James D. Heffelfinger, Kamal Ibne Amin Chowdhury, Shahriar Ahmed, Sadia Afreen, Mohammad Tauhidul Islam, S. M. Mazidur Rahman et al. · 2023 · PLoS ONE
  17. Epidemiology and antimicrobial resistance of Mycobacterium spp. in the United Arab Emirates: a retrospective analysis of 12 years of national antimicrobial resistance surveillance data
    Jens Thomsen, Najiba Mohamed Abdulrazzaq, Peter Suwirakwenda Nyasulu, Farida Ismail Al Hosani, Maya Habous, Stefan Weber, Fouzia Jabeen, Godfred Antony Menezes, Carole Ayoub Moubareck, Abiola Catherine Senok et al. · 2024 · Frontiers in Public Health
  18. Completion and Adverse Drug Events of Latent Tuberculosis Infection Treatment in Patients Receiving Dialysis: Predictors and Impacts of Different Regimens in a Prospective Cohort Study
    Shu‐Yung Lin, Jia‐Yih Feng, Chih‐Yuan Lee, Yi‐Chih Lin, Yu‐Hsiang Chou, Kuan‐Yin Lin, Yufeng Wei, Shu‐Wen Lin, Chin‐Hao Chang, Ping-Huai Wang et al. · 2020 · Antimicrobial Agents and Chemotherapy
  19. Performance of fine needle aspiration cytology and Ziehl-Neelsen staining technique in the diagnosis of tuberculosis lymphadenitis
    Kumbi, Hawi, Ali, Musa Mohammed, Abate, Alegntaw · 2024 · BMC Infectious Diseases
  20. Diagnostic accuracy study of STANDARD TB-Feron FIA and STANDARD TB-Feron ELISA tests for tuberculosis infection diagnosis in Eastern European setting
    Valeriu Crudu, Dumitru Chesov, Alexandru Codreanu, Nadejda Turcanu, Nelly Ciobanu, L. Nepoliuc, Doina Rusu · 2025 · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
  21. Effect of Bacillus Calmette-Guérin vaccination against Mycobacterium tuberculosis infection in children: an updated systematic review and meta-analysis
    Shunli Cai, Qingyi Luo, Guozhong Zhou, Xin Guo, Dong Yan, Hongbo Chen, Shiqi Luo, Jian Feng He, Yuan Xia, Hanse Li et al. · 2025 · International Journal of Infectious Diseases
  22. Detection for New Biomarkers of Tuberculosis Infection Activity Using Machine Learning Methods
    A. Yu. Starshinova, Albina R. Sabirova, Olesya Koroteeva, Kudryavtsev Igor, Artem Rubinstein, Arthur D. Aquino, Andrey S. Trulioff, E. N. Belyaeva, Anastasia Kulpina, Raul A. Sharipov et al. · 2026 · Diseases
  23. The tuberculogenic environment
    Mikaela C. Coleman, Claire Calderwood, Sian Magee, Frank Underwood, Tenzin Kunor, Collins Timire, Kavindhran Velen, Emily Lai-Ho MacLean, Madhukar Pai, Palwasha Yousafzai Khan et al. · 2026 · The Lancet Global Health
  24. The reliability of tuberculin skin test in the diagnosis of latent tuberculosis infection in psoriasis patients: A case‐control study
    Süheyla Sürücüoğlu, Aylin Türel Ermertcan, Tubanur Çetinarslan, Nuri Özkütük · 2020 · Dermatologic Therapy
  25. Risk of Serotonin Syndrome with Isoniazid
    Michael E. O’Brien, Ronak G. Gandhi, Camille N. Kotton, Meagan L. Adamsick · 2020 · Antimicrobial Agents and Chemotherapy
  26. Restricted Activation of the NF-κB Pathway in Individuals with Latent Tuberculosis Infection after HIF-1α Blockade
    Aline de Oliveira Rezende, Rafaella Santos Sabóia, Adeliane Castro da Costa, Diana Messala Pinheiro da Silva Monteiro, Adrielle Zagmignan, Luís Ângelo Macêdo Santiago, Rafael Cardoso Carvalho, Paulo Vitor Soeiro Pereira, Ana Paula Junqueira‐Kipnis, Eduardo Martins de Sousa · 2022 · Biomedicines
  27. Isoniazid preventive therapy completion between July-September 2019: A comparison across HIV differentiated service delivery models in Uganda
    Levicatus Mugenyi, Proscovia Namuwenge, Simple Ouma, Baker Bakashaba, Mastula Nanfuka, Jennifer M. Zech, Collins Agaba, Andrew Mijumbi Ojok, Fedress Kaliba, John Bossa Kato et al. · 2024 · PLoS ONE
  28. Machine learning model based on SERPING1, C1QB, and C1QC: A novel diagnostic approach for latent tuberculosis infection
    Linsheng Li, Zhuang Li, Ling Yang, Zhaoyang Ye, Ruizi Ni, Yajing An, Weiguo Zhao, Wenping Gong · 2024 · iLABMED
  29. Timing matters in macrophage/CD4+ T cell interactions: an agent-based model comparing Mycobacterium tuberculosis host-pathogen interactions between latently infected and naïve individuals
    Alexis Hoerter, Alexa Petrucciani, Jordan R. Bonifacio, Eusondia Arnett, Larry S. Schlesinger, Elsje Pienaar · 2025 · mSystems
  30. CD4 response of QuantiFERON-TB Gold Plus for positive consistency of latent tuberculosis infection in patients on dialysis
    Ping-Huai Wang, Shu‐Yung Lin, Susan Shih-Jung Lee, Shu‐Wen Lin, Chih‐Yuan Lee, Yu‐Feng Wei, Chin‐Chung Shu, Jann‐Yuan Wang, Chong‐Jen Yu · 2020 · Scientific Reports
  31. Would the Use of Artificial Intelligence in COVID-19 Patient Management Add Value to the Healthcare System?
    Manuel Cossio, Ramiro Eugenio Gilardino · 2021 · Frontiers in Medicine
  32. Comparison of a mycobacterial phage assay to detect viable Mycobacterium avium subspecies paratuberculosis with standard diagnostic modalities in cattle with naturally infected Johne disease
    Robert J. Greenstein, Liya Su, Irene R. Grant, Antonio C. G. Foddai, Amy Turner, Jason S. Nagati, Sheldon T. Brown, Judith K. Reffett · 2021 · Gut Pathogens
  33. MycoVarP: Mycobacterium Variant and Drug Resistance Prediction Pipeline for Whole-Genome Sequence Data Analysis
    Sandeep Swargam, Indu Kumari, Amit Kumar, Dibyabhaba Pradhan, Anwar Alam, Harpreet Singh, Anuja Jain, Kangjam Rekha Devi, Vishal Trivedi, Jogesh Sarma et al. · 2022 · Frontiers in Bioinformatics
  34. The cascade of care in tuberculosis infection screening and management in newly arrived refugees in Aarhus, Denmark
    Nina Breinholt Stærke, Andreas Fløe, Mie Fryd Nielsen, Mette Holm, Emma Holm, Ole Hilberg, Christian Morberg Wejse, Anne Mette Fløe Hvass · 2022 · Travel Medicine and Infectious Disease
  35. The Impact of Diabetes and Prediabetes on Prevalence of Mycobacterium tuberculosis Infection Among Household Contacts of Active Tuberculosis Cases in Ethiopia
    Alison Smith, Russell Ryan Kempker, Liya Wassie, Kidist Bobosha, Azhar Nizam, Neel R Gandhi, Sara C. Auld, Matthew James Magee, Henry M. Blumberg, Joel Ernst et al. · 2022 · Open Forum Infectious Diseases
  36. The Gene and Regulatory Network Involved in Ethambutol Resistance in Mycobacterium tuberculosis
    Funmilayo Grâce Boni, Insaf Hamdi, Liadrine Moukendza Koundi, Yongdong Dai, Kanshan Shrestra, M. A. Abo-Kadoum, Ulrich Aymard Ekomi Moure, Ismail Mohamed Suleiman, Jianping Xie · 2022 · Microbial Drug Resistance
  37. Elevated neopterin in tuberculosis and co-infection with HIV and the effect of treatment: A systematic review, meta-analysis, and meta-regression
    Amene Saghazadeh, Nima Rezaei · 2022 · International Immunopharmacology
  38. Screening of household contacts for TB infection in Cote d'Ivoire
    Raymond Kouassi N’Guessan, D.A. Baï Orsot, J.M. Ahui Brou, N’golo Bamba, M.E. Tchoutedjem Mefo, A.S. Bakayoko · 2024 · IJTLD OPEN
  39. Mycobacterium tuberculosis
    Yangyang Li, Rong-Jun Cai, Elizabeth A. Talbot, Yating Wang · 2024 · Elsevier eBooks
  40. High yield from repeated testing for tuberculosis among high-risk citizens in Denmark
    Nina Breinholt Stærke, Torben Smidt-Hansen, Leni Oldenborg, Torben Tranborg Jensen, Ulla Møller Weinreich, Shakil Shakar, Christian Morberg Wejse, Ole Hilberg, Andreas Fløe · 2020 · International Journal of Infectious Diseases
  41. Quality by Design (QbD) driven Systematic Development of Nano-lipoidal Carrier of Poorly Water Soluble Anti-tubercular agent-Rifabutin.
    Swapnil R. Patil, SG Gattani, Pradip Nirbhavane, Om Prakash Katare, Kiran Dayaram Patil · 2021 · Materials Technology
  42. Tuberculosis and COVID-19 Screening at Health Facilities: A Cross-Sectional Survey of Health Care Workers in Nigeria during the COVID-19 Pandemic
    Chika A. Okoro, Eridiong Ogbonna Onyenweaku, Emecheta G. Okwudire, Muriel K. Kalu, Oluremilekun Comfort Kusimo, Victor Williams · 2021 · Journal of Tuberculosis Research
  43. Mycobacterial formation of intracellular lipid inclusions is a dynamic process associated with rapid replication
    DM Fines, Denise Schichnes, M Knight, Andrea Anaya-Sanchez, NTT Thuong, Jeffery S. Cox, Sarah A. Stanley · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  44. The role of chest X-rays when screening for latent tuberculosis infection in patients with inflammatory bowel disease before starting biologic treatment
    Sebastian Bonde Christiansen, Mark Andrew Ainsworth · 2024 · Scandinavian Journal of Gastroenterology
  45. Prevalence of latent tuberculosis infection in older adults: a systematic review and meta-analysis
    Yuxiao Ling, Min Wang, Songhua Chen, Qian Wu, Yu Zhang, Kui Liu, Kehu Yang, Luyu Wang, Wei Wang, Bin Chen et al. · 2025 · Age and Ageing
  46. Identification and validation of a T-cell-related MIR600HG/hsa-mir-21-5p competing endogenous RNA network in tuberculosis activation based on integrated bioinformatics approaches
    Guo-Hu Hong, Qing Guan, Hong Peng, Xin-Hua Luo, Qing Mao · 2022 · Frontiers in Genetics
  47. A New Benzothiazolthiazolidine Derivative, 11726172, Is Active In Vitro , In Vivo , and against Nonreplicating Cells of Mycobacterium tuberculosis
    Elena G. Salina, Umberto Postiglione, Laurent Robert Chiarelli, Deborah Recchia, Monika Záhorszká, Alexander Lepioshkin, Natalia Monakhova, Adrian Pál, Alessio Porta, Giuseppe Zanoni et al. · 2022 · mSphere
  48. Tuberculosis Elimination: Myth or Achievable Target?
    Rosella Centis, Lia D’Ambrosio, Xhevat Kurhasani, Ivan Solovič, Giovanni Battista Migliori · 2023 · Archivos de Bronconeumología
  49. Preventive treatment for latent tuberculosis from Indian perspective
    Zia Hashim, Richa Tyagi, Gajendra Vikram Singh, Alok Nath, Surya Kant · 2023 · Lung India
  50. Prevalence, Risk Factors, and Result Features in the Detection of Latent Tuberculosis Infection in Thai Healthcare Workers Using QuantiFERON-TB Gold Plus
    Wiphat Klayut, Sopa Srisungngam, Sirilada Suphankong, Pantip Sirichote, Benjawan Phetsuksiri, Supranee Bunchoo, Chiranan Jakreng, Savitree Racksas, Ballang Uppapong, Janisara Rudeeaneksin · 2024 · Cureus
  51. Tuberculosis research advances and future trends: A bibliometric knowledge mapping approach
    Siddig İbrahim Abdelwahab, Manal Mohamed Elhassan Taha, Osama Albasheer, Abdullah Alharbi, Anas A. Ahmed, Amani Osman Abdelmola, Suhaila Abdalkarim Ali, Lamyaa Ahmed Mohamed El Hassan, Majid Ahmed Darraj, Amal Hashem Mohamed et al. · 2024 · Medicine
  52. Economic evaluation of diagnosis and treatment for latent tuberculosis infection among contacts of pulmonary tuberculosis patients in Thailand
    Panida Yoopetch, Olívia Wu, Jiraphun Jittikoon, Montarat Thavorncharoensap, Sitaporn Youngkong, Naiyana Praditsitthikorn, Surakameth Mahasirimongkol, Thunyarat Anothaisintawee, Wanvisa Udomsinprasert, Usa Chaikledkaew · 2024 · Scientific Reports
  53. Investigation of the prevalence of latent tuberculosis in cancer patients compared to non-cancer patients: a case-control study
    Masoud Mortezazadeh, Mehdi Karimi, M. Esfandbod, Abbas Mofidi, Nima Hemmati, Mehdi Kashani, Niyousha Shirsalimi, Seyyed Taher Seyyed Mahmoudi, Ehsan Kamali Yazdi · 2024 · Oncology Reviews
  54. Harnessing CRISPR-Cas9 as an anti-mycobacterial system
    Megha Sodani, Chitra Seetharam Misra, Devashish Rath, Savita Kulkarni · 2023 · Microbiological Research
  55. Latent TB in Indian pediatric population: An update on evidence gaps and research needs
    Suchitra Vishwambhar Surve, Kajal Naukariya, Ira Shah · 2023 · Indian Journal of Tuberculosis
  56. Varied trends of tuberculosis and HIV dual epidemics among different countries during 2000–2020: lessons from an ecological time-trend study of 9 countries
    Chelsi Preuc, Maheen Humayun, Zhenhua Yang · 2023 · Scandinavian Journal of Infectious Diseases
  57. Predicting stringent QuantiFERON-TB Gold Plus conversions in contacts of tuberculosis patients
    Sheng‐Wei Pan, Donald G. Catanzaro, Marva Seifert, Rehan R. Syed, Naomi Hillery, Mei-Lin Ho, Valeriu Crudu, Elena Tudor, Nelly Ciobanu, Alexandru Codreanu et al. · 2023 · Journal of Microbiology Immunology and Infection
  58. HBHA induces IL-10 from CD4+ T cells in patients with active tuberculosis but IFN-γ and IL-17 from individuals with Mycobacterium tuberculosis infection
    Mai Izumida, Haddijatou Jobe, Edward Coker, Amadou Barry, Momodou Rashid, Ismaila L. Manneh, Georgetta K. Daffeh, Koya Ariyoshi, Jayne S. Sutherland · 2024 · Frontiers in Immunology
  59. Mathematical modeling suggests heterogeneous replication of Mycobacterium tuberculosis in rabbits
    Vitaly V. Ganusov, Afsal Kolloli, Selvakumar Subbian · 2024 · PLoS Computational Biology
  60. Prediction of Conserved Peptides of Paracoccidioides for Interferon-γ Release Assay: The First Step in the Development of a Lab-Based Approach for Immunological Assessment during Antifungal Therapy
    Sarah Brena Aparecida Rosa, Bárbara Guimarães Csordas, Sandra Maria do Valle Leone de Oliveira, Amanda Ribeiro dos Santos, Anamaria Mello Miranda Paniago, James Venturini · 2020 · Journal of Fungi
  61. Screening for Parasitic Infection and Tuberculosis in Immunosuppressed and Pre-Immunosuppressed Patients: An Observational Study
    Luisa Carnino, Jean-Marc Schwob, Dionysios Neofytos, María Lazo-Porras, François Chappuis, Gilles Éperon · 2021 · Tropical Medicine and Infectious Disease
  62. Comparison of Interferon Gamma Release Assay and Tuberculin Skin Test for Diagnosis of Latent Tuberculosis in Psoriasis Patients Planned for Systemic Therapy
    Shekhar Neema, Sunmeet Sandhu, Sweta Mukherjee, Deepak Vashisht, Senkadir Vendhan, Anwita Sinha, Biju Vasudevan · 2022 · Indian Journal of Dermatology
  63. Novel Automation of an Enzyme-Linked Immunosorbent Spot Assay Testing Method: Comparable Diagnostic Performance of the T-SPOT. TB Test Using Manual Density Gradient Cell Isolation versus Automated Positive Selection with the T-Cell Select Kit
    Shuhua Wang, Murgesean V. S. Rajaram, André Phillip Trollip, Qian Wu, Doris Ayala, Danyelle Garza, Marielena A. Benavidez, Kelsie Fox, Génesis P. Aguillón-Durán, Erika A. Vargas-Orozco et al. · 2022 · Journal of Clinical Microbiology
  64. US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy
    Sonya Krishnan, Richard E. Chaisson · 2023 · Clinical Infectious Diseases
  65. TIGIT blockade improves anti-Mycobacterium tuberculosis immunity
    Jingyu Zhou, Qingluan Yang, Haoxin Xu, Huaxin Chen, Ning Jiang, Qinfang Ou, Mengqing Qian, Xing Lin, Yixuan Yang, Feiran Zhou et al. · 2025 · PLoS Pathogens
  66. A quadral biosignature of IFN-γ, IL-2, IL-12 and IP-10 increases the diagnostic potential for latent tuberculosis among diabetic patients in Uganda
    Phillip Ssekamatte, Diana Sitenda, Rose Nabatanzi, Marjorie Nakibuule, Davis Kibirige, Andrew Peter Kyazze, David Patrick Kateete, Bernard S. Bagaya, Obondo James Sande, Reinout van Crevel et al. · 2025 · BMC Immunology
  67. Reprogramming the host: Mycobacterium tuberculosis as a silent architect of the immuno-tumoral
    Rodolfo Chavez-Dominguez, Martha Torres, Atziri A. Acevedo-Domínguez, Jesús A. Ibarra-Inocente, Claudia Carranza · 2025 · Frontiers in Cellular and Infection Microbiology
  68. Prevalence estimates of tuberculosis infection in adults in Denmark: a retrospective nationwide register-based cross-sectional study, 2010 to 2018
    Anne Ahrens Østergaard, Troels Lillebæk, Inge Petersen, Andreas Fløe, Eliza H Worren Bøkan, Ole Hilberg, Inge Kristine Holden, Lone Larsen, Ada Colic, Christian Morberg Wejse et al. · 2024 · Eurosurveillance
  69. Adverse drug reactions following treatment of latent tuberculosis infection: a linked national tuberculosis surveillance with claims database
    Yu-Seon Jung, Sun-Young Jung, Jae-Eun Lee, Kyungeun Lee, Jae Chol Choi · 2024 · The Korean Journal of Internal Medicine
  70. Evaluating stratified T-SPOT.TB results for diagnostic accuracy in tuberculosis disease: a retrospective cohort study with sensitivities, specificities, and predictive values
    Ole Skouvig Pedersen, Søren Sperling, Anders Koch, Troels Lillebæk, Victor Næstholt Dahl, Andreas Fløe · 2025 · Clinical Microbiology and Infection
  71. Cost-effectiveness of screening with transcriptional signatures for incipient TB among U.S. migrants
    Yuli Lily Hsieh, Charles Robert Horsburgh, Ted Cohen, Jeffrey W. Miller, Joshua A. Salomon, Nicolas A. Menzies · 2025 · PLoS Medicine
  72. Barriers to treatment adherence among patients with tuberculosis: a qualitative study of Pakistani nationals and Afghan refugees
    Noor Sanauddin, Fayaz Ahmad, Maryiam Rahim, Mohammad Paracha, Zohaib Khan, Fatima Khalid Qazi, Shaista Rasool, Mirrat Gul Butt, Farooq Naeem, Muhammad Firaz Khan et al. · 2025 · BMJ Open
  73. The seedbeds of Tuberculosis: is it time to target congregate settings and workplaces?
    Montecucco, Montecucco, Guglielmo Dini, Alborz Rahmani, Laura Sticchi, Paolo Durando · 2020 · Journal of preventive medicine and hygiene
  74. It is time to optimise the management of latent tuberculosis infection in children
    Anne Christine Nordholm, Troels Lillebæk · 2021 · European Respiratory Journal
  75. Etiology of Fever and Associated Outcomes Among Adults Receiving Chemotherapy for the Treatment of Solid Tumors in Uganda
    Elizabeth A. Gulleen, Sarah Holte, Yuzheng Zhang, Immaculate Mbarusha, Dennis Mubiru, Bernadette Pedun, Michael Kenneth Keng, Scott Kirkland Heysell, Abrahams Omoding, Christopher Charles Moore et al. · 2023 · Open Forum Infectious Diseases
  76. Influential Factors of Tuberculosis Notification Rates in Turkey: A Provincial-Level Spatial Analysis
    Ahmet Naci Emecen, Pınar Kıran, Derya Çağlayan · 2024 · Thoracic research and practice
  77. Incidence of tuberculosis disease in individuals diagnosed with tuberculosis infection after screening: A population-based cohort study in South Korea
    Jaehee Lee, Dohyang Kim, Jinseub Hwang, Jin‐Won Kwon · 2024 · International Journal of Infectious Diseases
  78. A broader evaluation of vaccine-induced T cell immunity against tuberculosis
    Paul Ogongo · 2024 · Frontiers in Tuberculosis
  79. Epidemiology of Latent Tuberculosis in Rheumatic Immune-Mediated Inflammatory Diseases—Study of 1117 Patients and Descriptive Literature Review
    Joy Selene Osorio-Chávez, David Martinez-Lopez, Carmen Álvarez-Reguera, Virginia Portilla, José Manuel Cifrián Martínez, Santos Castañeda, Iván Ferraz‐Amaro, Ricardo Blanco · 2024 · Journal of Clinical Medicine
  80. Fewer losses in the cascade of care for latent tuberculosis with solo interferon-gamma release assay screening compared to sequential screening
    Rachel Lim, Rachel Talavlikar, O. Chiazor, Julia Bietz, Helena M. Gardiner, Dina Fisher · 2021 · BMC Infectious Diseases
  81. Deterministic and stochastic in-host tuberculosis models for bacterium-directed and host-directed therapy combination
    Wenjing Zhang · 2022 · Mathematical Medicine and Biology A Journal of the IMA
  82. Oxidation of the Mycobacterium tuberculosis key virulence factor protein tyrosine phosphatase A (MptpA) reduces its phosphatase activity
    Anna Niesteruk, Sridhar Sreeramulu, Hendrik R. A. Jonker, Christian Paolo Richter, Harald Schwalbe · 2022 · FEBS Letters
  83. Cholesterol-dependent activity of dapsone against non-replicating persistent mycobacteria
    Savannah E. R. Gibson, James Harrison, Antonia Molloy, Jonathan A. G. Cox · 2022 · Microbiology
  84. What's new in childhood tuberculosis
    Heather Finlayson, Juanita Lishman, Megan Palmer · 2023 · Current Opinion in Pediatrics
  85. Active and latent TB screening in recently arrived persons from Afghanistan: feasibility and lessons learned
    Laura Macfarlane, Seema O. Brij, Fran Child, Louise Turnbull, Alice Rhiannon Lee, Manuela Barrera, Celia Hogan · 2023 · Clinical Medicine
  86. Review Article: Virulence Factors of Mycobacterium Tuberculosis
    Israa N. H. Al-Asady, Jassim Fatehi Ali · 2023 · Journal for Research in Applied Sciences and Biotechnology
  87. Epidemiology and Treatment Outcomes of Tuberculosis With Chronic Hepatitis B Infection—California, 2016–2020
    J Bradford Bertumen, Lisa Pascopella, Emily E. Han, Rosie Glenn-Finer, Robert J. Wong, Amit S. Chitnis, Devan Jaganath, Mirna Ponce Jewell, Prabhu P. Gounder, Sara McElroy et al. · 2024 · Clinical Infectious Diseases
  88. Reactivities of 4-amino salicylic acid and its ‘Green’ inhibition into nano sized β-cyclodextrin for Anti-Tuberculosis drug delivery
    Shruti Sharma, Pooja Yadav, Meenakshi M. Rana, Papia Chowdhury · 2024 · Journal of Molecular Liquids
  89. Growth-inhibitory effects of tris-(1,10-phenanthroline) iron (II) against Mycobacterium tuberculosis in vitro and in vivo
    Mariana Cristina Solcia, Debora Leite Campos, Júlia Araújo Grecco, Caio Sander Paiva Silva, Patrícia Bento da Silva, Isabel Cristiane da Silva, Ana Paula Balduino da Silva, Joás Silva, Fernando Bombarda Oda, André Gonzaga dos Santos et al. · 2021 · Tuberculosis
  90. Is the EU model for contact investigation applicable to high TB burden settings?
    Jean-Pierre Zellweger · 2020 · International Journal of Infectious Diseases
  91. Ultrasound-guided management of tuberculosis-related pleural effusion in a pediatric patient: A case report and literature review
    Salvatore Michele Carnazzo, Carla Cerruto, Francesco Fabrizio Comisi · 2024 · Radiology Case Reports
  92. Mycobacterium tuberculosis Infects Human Visceral White Adipocytes and Expresses Dormancy Genes and Inflammatory Cytokines: The Role of Visceral Adipocytes in Latent Tuberculosis Infection
    Ana E. Garduño-Torres, Manuel G. Salgado-Cantú, Silvia Guzmán‐Beltrán, Jesús Montoya‐Ramírez, Juan Antonio Suárez‐Cuenca, Enrique Ortega, Ricardo Orozco-Solís, Daniela I. Uribe-López, María Teresa Herrera, Luis Horacio Gutiérrez-González et al. · 2025 · International Journal of Molecular Sciences
  93. Recommendations on the Diagnosis and Treatment of Tuberculosis Infection: SEPAR/SEIMC/Spanish Ministry of Health Consensus Statement
    José Antonio Caminero, Luis Anibarro, Eva María Tabernero, Fernando Alcaide, Guillermo Pérez-Mendoza, Joan-Pau Millet, Remedio Guna, María Luiza de Souza-Galvão, Paula López-Roa, Adrián Sánchez‐Montalvá et al. · 2026 · Archivos de Bronconeumología
  94. The detection of mixed tuberculosis infections using culture filtrate and resuscitation promoting factor deficient filtrate
    M. Chengalroyen, G. Beukes, K. Otwombe, B. Gordhan, N. Martinson, B. Kana · 2022 · Frontiers in Cellular and Infection Microbiology
  95. Identification of novel inhibitors for trigger factor (TF) of M. tb : an in silico investigation
    Masuma Khawary, Saurabh Pandey, Omprakash Sharma, Raunak Raunak, Manish Sharma, Ruchi Malik, Deeksha Tripathi · 2023 · Journal of Biomolecular Structure and Dynamics
  96. Using immune clusters for classifying Mycobacterium tuberculosis infection
    Xiaochen Wang, Guoxing Tang, Yi Huang, Huijuan Song, Siyu Zhou, Liyan Mao, Ziyong Sun, Zhigang Xiong, Shiji Wu, Hongyan Hou et al. · 2024 · International Immunopharmacology
  97. Mycobacterium tuberculosis latent infection in healthcare students: systematic review of prevalence
    Lima Renata Silva de, Silva Rodrigo Nogueira da, André Suzana Rosa, Pinheiro Ana Kedma Correa, Sousa Ana Inês, Silva Ingrid Fabiane Santos da, Santos Juliano dos, Nogueira Laura Maria Vidal, Zeitoune Regina Célia Gollner · 2024 · Revista da Escola de Enfermagem da USP
  98. Does perceived social support buffer the impact of psychological distress on health-related quality of life among people living with tuberculosis?
    Desmond Uchechukwu Onu, Christy Ngozi Obi-keguna, Ike Ernest Onyishi, Elisha John Igwe · 2025 · Psychology Health & Medicine
  99. Prevalence and Risk Factors of Latent Tuberculosis Infection Detected by IGRA in Patients with Immune-Mediated Inflammatory Diseases Before and During Biologic DMARD Therapy (TITAN Study)
    José Antonio Mata-Marín, Marisol Apaez-Iglesias, Ana Luz Cano-Díaz, Juan Pablo Sánchez-Navarro, Diana Edith Fernández-Madinaveitia, Gustavo Barriga-Angulo, Salma Triana-González, Alberto Chaparro-Sánchez, Ericka Nelly Pompa-Mera, Jesús Gaytán‐Martínez · 2025 · Journal of Clinical Medicine
  100. A human YEATS4 variant confers resistance to TST and IGRA conversion despite Mycobacterium tuberculosis exposure
    Clément Conil, Jonathan Bohlen, Elouise E. Kroon, Marc Antoine Jean Juste, Jérémy Manry, Matthieu Chaldebas, James M. Bean, Kathleen Frances Walsh, Monica Dallmann-Sauer, Maxime Rotival et al. · 2025 · Genome Medicine